5 results
8-K
EX-99.1
INVA
Innoviva Inc
9 Sep 13
Other Events
12:00am
UMEC/VI
125/25
(N=226)
UMEC
(N=227)
Placebo
(N=109)
Total
Age, years
Males, n (%)
Ethnicity, n (%)
Hispanic/Latino
Not Hispanic/Latino
Smoking
8-K
EX-99
INVA
Innoviva Inc
10 Oct 06
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
12:00am
Baseline Demographic & Disease Characteristics 20% 14% 6% 22% 14% 5% Hispanic Black Asian 69 : 31 68 : 32 US: Non-US Race 12% 12% CrCl < 50 mL / min
- Prev
- 1
- Next